Edition:
United States

Insider Trading: Osiris Therapeutics Inc (OSIR.OQ)

OSIR.OQ on NASDAQ Stock Exchange Global Market

4.78USD
23 Sep 2016
Change (% chg)

$-0.11 (-2.25%)
Prev Close
$4.89
Open
$4.80
Day's High
$4.85
Day's Low
$4.77
Volume
12,923
Avg. Vol
25,433
52-wk High
$19.12
52-wk Low
$3.55

FRIEDLI PETER

Institutional Holders

% Shares Owned: 36.16%
# of Holders: 105
Total Shares Held: 12,456,847
3 Mo. Net Change: -207,160
# New Positions: 7
# Closed Positions: 25
# Increased Positions: 37
# Reduced Positions: 48
# Net Buyers: -11

Officers & Directors

Name Age Since Current Position

Peter Friedli

62 Chairman of the Board

David Dresner

68 2016 Interim President and Chief Executive Officer

Gregory Law

49 2015 Chief Financial Officer, Corporate Secretary and Treasurer

Frank Czworka

46 2014 Vice President, General Manager of Wound Care

Adrian Mollo

41 2014 General Counsel

Alla Danilkovitch

51 2015 Chief Scientific Officer

Thomas Brandt

63 2016 Independent Director

Jay Moyes

61 2006 Independent Director

Aziz Ahmad

IR Contact